More than 10,000 clinical trials are ongoing, and a growing number of scientists are taking their expertise to the field.
These trials are in a range of medical devices, including pacemakers, prosthetics and devices for the heart.
The latest update comes from a new analysis of the FDA’s electronic drug product applications database, which tracks drug approval applications from October 2016 to September 2017.
More than 8,000 drug applications were reviewed, according to the FDA, and about 8,700 were in clinical trials.
The vast majority of the submissions were submitted by drug companies.
The number of clinical trials that were approved by the FDA for approval this year was more than 10.4 million, with 1.6 million clinical trials submitted.
The FDA said that nearly 8,300 applications were submitted this year for the approval of new drugs.
The top five submissions are: pacemaking devices, heart pacematics, prosthetic devices, and implantable devices for heart disease.
In all, 3,829 applications were filed in 2017.
The top three drugs for the FDA approved this year were: amantadine, nifedipine, and ritonavir.